Cargando…
A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
The objective of the study was to examine whether disease duration independently predicts treatment response among biologic-naïve patients with rheumatoid arthritis (RA) initiating abatacept in clinical practice. Using the Corrona RA registry (February 2006–January 2015), biologic-naïve patients wit...
Autores principales: | Harrold, Leslie R., Litman, Heather J., Connolly, Sean E., Kelly, Sheila, Hua, Winnie, Alemao, Evo, Rosenblatt, Lisa, Rebello, Sabrina, Kremer, Joel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486472/ https://www.ncbi.nlm.nih.gov/pubmed/28251392 http://dx.doi.org/10.1007/s10067-017-3588-7 |
Ejemplares similares
-
Comparative Effectiveness of Abatacept Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis Who Are Anti-CCP Positive in the United States Corrona Registry
por: Harrold, Leslie R., et al.
Publicado: (2019) -
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren’s syndrome enrolled in a large observational US registry
por: Harrold, Leslie R., et al.
Publicado: (2020) -
Prevalence of Sjögren’s syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry
por: Harrold, Leslie R., et al.
Publicado: (2020) -
Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA
por: Harrold, Leslie R., et al.
Publicado: (2021) -
Improvements in Fatigue in 1536 Patients with Rheumatoid Arthritis and Correlation with Other Treatment Outcomes: A Post Hoc Analysis of Three Randomized Controlled Trials of Abatacept
por: Gossec, Laure, et al.
Publicado: (2017)